Related Experiment Video
Updated: Sep 3, 2025

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
A Case-Control Study Evaluating Risk Factors and Outcomes of Hospitalized Children With ESBL-UTI
Sophia Hassor1, Veronica Etinger1, Diana Sofia Villacis1
1Nicklaus Children's Hospital, Miami, FL, USA.
Insights
This study identified risk factors for extended-spectrum beta-lactamase-producing (ESBL) urinary tract infections (UTIs) in children. Many children with ESBL-UTI responded to antibiotics, but longer hospital stays and IV antibiotic use were noted.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Clinical epidemiology
Background:
- Urinary tract infections (UTIs) are a common cause of pediatric hospitalization.
- There is a growing concern regarding the prevalence of extended-spectrum beta-lactamase-producing (ESBL) organisms in pediatric UTIs.
Purpose of the Study:
- To identify risk factors associated with ESBL-UTI in hospitalized children.
- To evaluate treatment outcomes for children diagnosed with ESBL-UTI.
Main Methods:
- A retrospective case-control study was conducted between July 2014 and December 2017.
- Medical records of hospitalized children with positive urine cultures were reviewed.
- Cases were defined as ESBL-UTI, and controls as non-ESBL-UTI.
Main Results:
- Identified risk factors for ESBL-UTI include previous UTI, recent antibiotic use, urinary tract abnormalities, recent hospitalization, and nonrenal comorbidities.
- The majority of children with ESBL-UTI showed positive responses to discordant antibiotics.
- Patients with ESBL-UTI experienced longer hospital stays and required more prolonged intravenous antibiotic therapy.
Conclusions:
- Specific risk factors predispose children to ESBL-UTI.
- While treatment with discordant antibiotics can be effective, ESBL-UTI is associated with increased healthcare resource utilization.
Abstract:
Urinary tract infections (UTIs) are among the most common causes of hospitalization in children, with a rising prevalence of extended-spectrum beta-lactamase-producing organisms (ESBL). The purpose of this study was to identify risk factors and treatment outcomes of children with ESBL-UTI. A retrospective case-control study of hospitalized children was performed from July 2014 till December 2017. Medical records from patients with a positive urine culture were reviewed and included in the study if they met criteria for UTI. Cases were defined as ESBL-UTI, while controls were defined as non-ESBL-UTI patients. This study confirmed that there are certain risk factors, such as previous UTI, recent antibiotic use, urinary tract abnormalities, recent hospital admission, and nonrenal comorbidities, that are associated with ESBL-UTI. Most of the patients with ESBL-UTI responded to discordant antibiotics. Other significant outcomes in patients with ESBL-UTI included a longer length of stay and longer intravenous antibiotic therapy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urinary Tract Infection I: Introduction

